S
688163
vs
U
USBC
S
688163
U
USBC
Over the past 12 months, Shanghai Serum Bio-Technology Co Ltd has underperformed USBC, delivering a return of +45% compared to the USBC's +389 900% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
688163
USBC
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Shanghai Serum Bio-Technology Co Ltd Intrinsic Value
HIDDEN
USBC Intrinsic Value
HIDDEN
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
|
25.92
CNY
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.39
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
688163, USBC
688163, USBC
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Shanghai Serum Bio-Technology Co Ltd
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
688163, USBC
688163, USBC
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Shanghai Serum Bio-Technology Co Ltd
SSE:688163
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Shanghai Serum Bio-Technology Co Ltd
77.4%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
Operating Margin
Shanghai Serum Bio-Technology Co Ltd
23.8%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
Net Margin
Shanghai Serum Bio-Technology Co Ltd
22.7%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
FCF Margin
Shanghai Serum Bio-Technology Co Ltd
-18%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROE
Shanghai Serum Bio-Technology Co Ltd
4.1%
USBC
-51.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROA
Shanghai Serum Bio-Technology Co Ltd
4%
USBC
-37.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROIC
Shanghai Serum Bio-Technology Co Ltd
12.3%
USBC
-31.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROCE
Shanghai Serum Bio-Technology Co Ltd
4.2%
USBC
-30.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shanghai Serum Bio-Technology Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
Solvency Comparison
S
Shanghai Serum Bio-Technology Co...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
688163, USBC
688163, USBC
Performance Gap
688163, USBC
688163, USBC
Performance Gap Between 688163 and USBC
HIDDEN
Performance By Year
688163, USBC
688163, USBC
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 688163 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Shanghai Serum Bio-Technology Co Ltd
ABBV
Abbvie Inc
Cheaper
vs Shanghai Serum Bio-Technology Co Ltd
ATXS
Astria Therapeutics Inc
More expensive
vs Shanghai Serum Bio-Technology Co Ltd
AMGN
Amgen Inc
Cheaper
vs Shanghai Serum Bio-Technology Co Ltd
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
